One contact point: Feasibility Manager
The process of the possibility to conduct a clinical trial (feasibility process) verified in all sites at the same time
Verification of patients’ databases
Continuous contact with principal investigators, key opinion leaders
we smoothly
start new project
Our group’s feasibility assessment is a fast and coordinated process, conducted through a single point of contact and consistent communication. A single inquiry is enough to receive a response from the seven research centres within the Penta Hospitals Poland group.
Recruitment potential is analyzed based on:
Thanks to that we are able to reliably assess recruitment possibilities in specific locations, taking into account both real data and the specific character of conducting trials in a given indication.
We offer not only hard numerical and operational data, but also expert feedback on the proposed protocol and the potential challenges related to its execution.
If needed, we also ensure the possibility of our most experienced investigators to deeply evaluate draft versions of protocols.
One wording. One budget. A cohesive process.
Step 1
A person dedicated for concluding contracts
Step 2
Three-party contracts
Step 3
Fast process of negotiating the budget and contract wording
Step 4
One contract template common for all sites
The contracting process at Penta Hospitals Poland is based on common formal and budget assumptions, which allows to significantly simplify and speed up negotiations with all sites involved in a given project.
We guarantee:
We ensure full transparency in pricing and provide hard data and detailed justifications for budget negotiations.
Each of our sites has its own quality procedures, tailored to the specific nature of their functioning. What unites us as a group is a shared approach to active quality management; an approach that is based on predicting risks, preventing deviations, and immediately responding to non-compliance, in collaboration with our partners: sponsors and CROs.
We believe that high quality is only possible with real engagement of all parties. We openly accept feedback from sponsors and CROs, and we are flexible in modifying our processes to best suit the specific needs of the trial.
The effectiveness of this approach is confirmed in practice: we have successfully completed over 30 audits and inspections. We believe that good quality starts with good education. That is why, as part of the network, we offer our employees:
Database
Referral system
Marketing
Our recruitment activities are based primarily on our own patient database and the network of doctors cooperating with our site, both within the Penta Hospitals Poland group (20 hospitals, 18 clinics) and in a model of long-term external cooperation.
We currently have a patient database reaching 1.2 million /year.
Patients often remain in one, well-known to them system of health care, which promotes both a smooth transition from the therapeutic to the research process and high retention throughout the study.
As part of the Penta Hospitals Poland capital group, we use a network of referrals: doctors, specialists and other medical personnel interested in providing information about our clinical trials to potential participants.
Each activity related to planning the recruitment strategy is preceded by an interview with an investigator who has direct patient contact, ensuring the development of a viable route to patient access. This way, recruitment strategies are adjusted to the characteristics of the population studied in the trial.
Already at the startup stage, we develop a recruitment strategy adjusted to the specific needs of the research. Research teams get support from our recruitment specialists who:
For example, in endpoint projects (based on a defined endpoint) we rely mainly on our own patients, and in large-population studies (e.g. vaccine studies) we engage a wide network of referring doctors.
Additionally, our sites operate in smaller towns, which allows us to reach so-called “trial-naive” patients outside large urban areas and increases population diversity, which is so important in clinical trials.
Trials in a paediatric population
We conduct trials involving children and adolescences, within such areas as psychiatry, dermatology, and infectious diseases.
Selected sites in our group:
Research using controlled substances, including psychedelics
We conduct clinical trials involving therapies using controlled psychotropic and narcotic substances, with specific specialization in I-P substances such as psilocybin, 5-MeO-DMT, and LSD.
We have:
